- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04613505
Determining Parental Attitudes Toward Day of Surgery Consent for Research
February 6, 2025 updated by: Katherine Taylor, The Hospital for Sick Children
There are no studies examining parents' attitudes towards day of surgery consent for research.
The purpose of the study is to determine the attitudes parents of potential research participants have toward being approached for day of surgery consent.
The primary objective is to determine parental attitudes regarding day of surgery consent for anesthesia research.
The secondary objective is to determine the boundaries for day of surgery consent (e.g., study types, interventions, risk factors).
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This is a multi-phase prospective cohort study.
In the first phase the investigators will interview parents and consult the Family Research Advisory Committee (FRAC) to determine their attitudes toward day of surgery research consent.
The investigators will use the participants' responses and instruments already found in the literature to develop the questionnaire.
In the second phase, the investigators will interview parents and consult FRAC about the questionnaire to determine which items to add, remove, or modify.
In the third phase, the investigators will distribute the adapted questionnaire to clarify parents' attitudes surrounding day of surgery consent.
The investigators will use the results of the third phase to develop a table of guidelines for day of surgery consent.
In the final phase, the investigators will interview parents, healthcare professionals, and consult FRAC for feedback and modification of the table of guidelines.
Study Type
Observational
Enrollment (Actual)
214
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- The Hospital for Sick Children
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 day to 18 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
All participants receiving same day surgery at our institution are eligible to participate.
Description
Inclusion Criteria:
- The parents of children undergoing elective surgical procedures at Sickkids will be invited to participate in the study.
- If multiple parents are present, they are permitted to participate jointly; however, their participation will count as a single response.
Exclusion Criteria:
-Parents of children who are undergoing urgent or add-on procedures will be excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Phase 1: Instrument Development
Parents will be asked to participate in a semi-structured interview with one of the researchers that will explore their attitudes toward day of surgery consent.
Particular attention will be given to a) study designs, b) previous research experience, and c) previous medical experiences.
|
Participants will be asked a set of questions as applicable to each phase.
Researchers will be able to ask additional questions as they arise within each interview.
|
|
Phase 2: Questionnaire Adaptation
Parents will be given approximately 5 minutes to review a questionnaire we developed using participant responses in Phase 1.
After reviewing the questionnaire, participants will be asked to participate in a semi-structured interview with one of the investigators.
|
Participants will be asked a set of questions as applicable to each phase.
Researchers will be able to ask additional questions as they arise within each interview.
|
|
Phase 3: Questionnaire Application & Development of Day of surgery consent Table of Guidelines
Participants will be asked to complete the questionnaire developed in Phase 2.
|
A questionnaire (yet to be developed) will be administered to participants.
|
|
Phase 4: Table of Guidelines Refinement
Participants will be given approximately 5 minutes to review the table of guidelines developed in Phase 3.
After reviewing the guidelines, participants will be asked to participate in a semi-structured interview with one of the investigators.
|
Participants will be asked a set of questions as applicable to each phase.
Researchers will be able to ask additional questions as they arise within each interview.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parental attitude towards day of surgery consent
Time Frame: Day of surgery
|
Semi-structured interviews
|
Day of surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Boundary for day of surgery consent
Time Frame: Day of surgery
|
Semi-structured interview
|
Day of surgery
|
|
Boundary for day of surgery consent
Time Frame: Day of surgery
|
Questionnaires to be developed in phases 1 and 2 of the study
|
Day of surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Katherine Taylor, Staff Anesthesiologist
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 22, 2020
Primary Completion (Actual)
December 31, 2022
Study Completion (Actual)
December 31, 2022
Study Registration Dates
First Submitted
October 2, 2020
First Submitted That Met QC Criteria
November 2, 2020
First Posted (Actual)
November 3, 2020
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 6, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- 1000066221
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.